Drug Product
Excipients & Specialty Ingredients
Analytical & Bioanalytical Services
Company Overview
About
DelsiTech Ltd is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Finland
Founded:2014
Employees:1,600
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Europe
Regulatory Approvals
Drug Approval B0D9DF
FDA · #APR-SY629WJL · 2020-07-01
Drug Approval GD6KBF
Health Canada · #APR-M4BJ1XIS · 2022-01-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-L4DK8U0V
Issued: 2020-01-07
Expires: 2025-11-17
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-4I6YLFJ5
Issued: 2020-09-09
Expires: 2025-06-15
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-S9PN33PT
Issued: 2020-08-27
Expires: 2025-02-04
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-NLOSW2EE
Issued: 2020-02-09
Expires: 2025-03-16
Loading CDMO intelligence...
Key facts about DelsiTech Ltd
- DelsiTech Ltd is headquartered in Finland.
- DelsiTech Ltd was founded in 2014.
- DelsiTech Ltd has 1,600 employees.
- DelsiTech Ltd's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like DelsiTech Ltd
Directory pages this company appears in, each with the full list of matching manufacturers.